Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Ticho Barry, Directeur Médical. Director active across 1 company, notably Stoke Therapeutics, Inc.. Aggregated, 46 filings have been recorded. Split: 0 buy · 28 sells. Total volume traded: €3.2m. Activity tracked since 13 July 2021. The latest transaction was filed on 14 August 2026 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Ticho Barry
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13,945 shares@ US$12.77755.3% of flowCommon StockSEC:0001415889-24-028892:0
25 of 46 declarations
About Ticho Barry
Ticho Barry is Chief Medical Officer at Stoke Therapeutics, Inc. (XNAS). He has 41 filings in total, and the recent filings tracked run from 2021-07-15 to 2026-07-06, with EUR 0 in purchases and EUR 2,838,042 in sales.